6:19 PM
 | 
Feb 02, 2009
 |  BC Extra  |  Company News

Eastbourne proposes Amylin board nominees

Eastbourne Capital Management said it plans to nominate a slate of five directors for election to the 12-member board of diabetes company Amylin (NASDAQ:AMLN). Eastbourne's proposed nominees...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >